A scoping review of development and application of decision support tools for lung cancer screening

LIN Xiujing; LI Yonglin; LEI Fang; HUANG Feifei

doi:10.16460/j.issn1008-9969.2025.08.046

PDF(935 KB)

Journal of Nursing ›› 2025, Vol. 32 ›› Issue (8) : 46-51. DOI: 10.16460/j.issn1008-9969.2025.08.046

A scoping review of development and application of decision support tools for lung cancer screening

LIN Xiujing¹, LI Yonglin¹, LEI Fang², HUANG Feifei¹

Author information +

History +

Abstract

Objective To conduct a scoping review of studies on decision support tools for lung cancer screening at home and abroad, analyzing the current status of the development and application, and to provide reference for the localization and implementation of such tools. Methods Databases including CNKI, Wangfang, China Biology Medicine disc, VIP, PubMed, Embase, PsycINFO, CINAHL, Web of Science, Cochrane Library and JBI Library were systematically searched from the inception to August, 2024. The included literatures were summarized and analyzed. Results A total of 14 articles were included, identifying 7 decision support tools for lung cancer screening in various formats: videos (n=2), manuals (n=3) and web pages (n=2). Four decision support tools provided information on the development process, and 10 studies evaluated the effectiveness of 5 tools. Conclusion The development of decision support tools for lung cancer screening is not standardized, and the application system is not complete. In the future, building upon global theoretical frameworks while incorporating China-specific contexts, localized and high-quality decision support tools for lung cancer screening could be introduced or developed.

Key words

lung cancer / early detection of cancer / shared decision making / decision support tool / scoping review

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIN Xiujing, LI Yonglin, LEI Fang, HUANG Feifei. A scoping review of development and application of decision support tools for lung cancer screening[J]. Journal of Nursing. 2025, 32(8): 46-51 https://doi.org/10.16460/j.issn1008-9969.2025.08.046

References

[1] 陈良安. 早期肺癌诊断中国专家共识(2023年版)[J]. 中华结核和呼吸杂志, 2023, 46(1):1-18. DOI:10.3760/cma.j.cn112147-20220712-00592.
[2] Russell P, Harris, Stacey L,et al.The harms of screening: a proposed taxonomy and application to lung cancer screening[J].JAMA Intern Med, 2014,174(2):281-285. DOI:10.1001/jamainternmed.2013.12745.
[3] 郑红颖,胡嘉乐,董柏君,等. 医患共享决策评估工具的研究进展[J]. 中华护理杂志, 2018, 53(5):622-625. DOI:10.3761/j.issn.0254-1769.2018.05.023.
[4] 李玉,叶志霞,刘佩玉,等. 癌症患者治疗决策辅助的研究进展[J]. 中华护理杂志, 2017, 52(1): 28-33. DOI:10.3761/j.issn.0254-1769.2017.01.006.
[5] 张丰翼,刘素婷,张立力. 决策辅助工具在癌症患者生育力保护中的应用进展[J]. 中华护理杂志, 2023, 58(6): 689-694. DOI:10.3761/j.issn.0254-1769.2023. 06.007.
[6] 白雅萍,施婧.共享决策在心脏瓣膜病介入治疗患者中的应用研究进展[J].护理学报,2024,31(7):32-35. DOI:10.16460/j.issn1008-9969.2024.07.032.
[7] 牟玮,陆翠,王云云,等. 患者决策辅助工具国际标准4.0版的引进与评估[J]. 医学与哲学, 2019, 40(18): 11-17.
[8] Lockwood C, Dos Santos KB, Pap R.Practical guidance for knowledge synthesis: scoping review methods[J]. Asian Nurs Res 2019, 13(5): 287-294. DOI:10.1016/j.anr.2019.11.002.
[9] 王喜益,叶志弘,汤磊雯. 范围综述在护理领域的应用进展[J]. 中华护理杂志, 2019, 54(8): 1259-1263. DOI:10.3761/j.issn.0254-1769.2019.08.030.
[10] Volk RJ, Linder SK, Leal VB, et al.Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography[J]. Prev Med, 2014(62):60-63. DOI:10.1016/j.ypmed.2014.02.006.
[11] Hoffman AS, Hempstead AP, Housten AJ, et al.Using a patient decision aid video to assess current and former smokers’ values about the harms and benefits of lung cancer screening with low-dose computed tomography[J]. MDM Policy Pract, 2018, 3(1):2381468318769886. DOI:10.1177/2381468318769886.
[12] Volk RJ, Lowenstein LM, Leal VB, et al.Effect of a patient decision aid on lung cancer screening decision-making by persons who smoke: a randomized clinical trial[J]. JAMA Netw Open, 2020, 3(1): e1920362. DOI:10.1001/jamanetworkopen.2019.20362.
[13] Reuland DS, Cubillos L, Brenner AT, et al.A pre-post study testing a lung cancer screening decision aid in primary care[J]. BMC Med Inform Decis Mak, 2018, 18(1): 5. DOI:10.1186/s12911-018-0582-1.
[14] Manners D, Pettigrew S, Lake FR, et al.Development and evaluation of a consumer information resource, including patient decision aid, for lung cancer screening: a quasi-experimental study[J]. Transl Behav Med, 2020, 10(2): 404-412. DOI:10.1093/tbm/ibz029.
[15] Lau YK, Caverly TJ, Cao P, et al.Evaluation of a personalized, web-based decision aid for lung cancer screening[J]. Am J Prev Med, 2015, 49(6): e125-e129. DOI:10.1016/j.amepre.2015.07.027.
[16] Lau YK, Caverly TJ, Cherng ST, et al.Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol[J]. JMIR Res Protoc, 2014, 3(4): e78. DOI:10.2196/resprot.4039.
[17] Crothers K, Kross EK, Reisch LM, et al.Patients’ attitudes regarding lung cancer screening and decision aids: a survey and focus group study[J].Ann Am Thorac Soc, 2016, 13(11): 1992-2001.DOI:10.1513/AnnalsATS.201604-289OC.
[18] Mazzone PJ, Tenenbaum A, Seeley M, et al.Impact of a lung cancer screening counseling and shared decision-making visit[J]. Chest, 2017, 151(3): 572-578. DOI:10.1016/j.chest.2016.10.027.
[19] Lau YK, Bhattarai H, Caverly TJ, et al.Lung cancer screening knowledge, perceptions and decision making among African Americans in Detroit, Michigan[J].Am J Prev Med, 2021,60(1):e1-e8.DOI:10.1016/j.amepre.2020.07.004.
[20] Carter-Harris L, Comer RS, Goyal A, et al.Development and usability testing of a computer-yailored decision support tool for lung cancer screening: study protocol[J]. JMIR Res Protoc, 2017, 6(11): e225. DOI:10.2196/resprot.8694.
[21] Carter-Harris L, Comer RS, Slaven Ii JE, et al.Computer-tailored decision support tool for lung cancer screening: community-based pilot randomized controlled trial[J]. J Med Internet Res, 2020, 22(11): e17050. DOI:10.2196/17050.
[22] Lowenstein LM, Deyter GMR, Nishi S, et al.Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs[J]. Transl Lung Cancer Res, 2018, 7(3): 254-271. DOI:10.21037/tlcr.2018.05.10.
[23] Reuland DS.Using deliberative methods to guide implemetation of lung cancer screening[C]. 37th Annual Meeting of the Society for Medical Decision Making, 2015.
[24] MD Anderson Cancer Center. Lung cancer screening: is it right for me?[EB/OL].(2014-12-23) [2023-05-20]. https://mediaplayer.mdanderson.org/video-full/902B8A3C-3800-461B-A6B2-80BA3EA1B4A4.
[25] Daniel Reuland. “CHOICE: should I start having yearly screening for lung cancer”[EB/OL]. (2015-11-12) [2021-04-22].https://mediaplayer.mdanderson.org/video-full/902B8A3C-3800-461B-A6B2-80BA3EA1B4A4.
[26] American Thoracic Society. “Decision aid for lung cancer screening with computerized tomography”[EB/OL].(2015-01-23)[2022-05-02]. https://www.thoracic.org/patients/patient-resources/.
[27] University of Michigan. Lung cancer screening should i get screened?[EB/OL].(2021-07-10)[2021-02-25].https://shouldiscreen.com/English/home.
[28] Lisa Carter-Harris. Lung Talk[EB/OL].(2020-11-16)[2021-04-20]. https://lungtalk.iupui.edu/.
[29] Health Decision. Lung cancer screening decision support tool[EB/OL].(2017-05-05)[2019-01-20]. https://more.ebsco.com/cp-health-decision-temp1878053lp.html.
[30] Carter-Harris L,Davis LL, Rawl SM.Lung cancer screening participation: developing a conceptual model to guide research[J]. Res Theory Nurs Pract, 2016, 30(4): 333-352. DOI:10.1891/1541-6577.30.4.333.
[31] 李学靖, 赵俊强, 张小艳,等 . 渥太华决策支持框架内涵及其临床应用的范围综述[J]. 中华护理杂志, 2022,57(6):756-762. DOI:10.3761/j.issn.0254-1769.2022.06.017.
[32] Witteman HO, Maki KG, Vaisson G, et al.Systematic development of patient decision aids: an update from the IPDAS collaboration[J]. Med Decis Making, 2021, 41(7): 736-754. DOI:10.1177/0272989X211014163.
[33] Coulter A, Stilwell D, Kryworuchko J, et al.A systematic development process for patient decision aids[J].BMC Med Inform Decis Mak, 2013, 13(Suppl 2): S2. DOI:10.1186/1472-6947-13-S2-S2.
[34] Elwyn G, O’connor A, Stacey D, et al.Developing a quality criteria framework for patient decision aids: online international Delphi consensus process[J]. BMJ, 2006, 333(7565): 417. DOI:10.1136/bmj.38926.629329.AE.
[35] Kim YW, Kang HR, Kwon BS, et al.Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers[J]. Eur Respir J, 2020, 56(5):2000177. DOI:10.1183/13993003.00177-2020.
[36] Gao S, Li N, Wang S, et al.Lung cancer in People’s Republic of China[J]. J Thorac Oncol, 2020, 15(10): 1567-1576. DOI:10.1016/j.jtho.2020.04.028.
[37] Ten Haaf K, Bastani M, Cao P, et al.A comparative modeling analysis of risk-Based lung cancer screening strategies[J]. J Natl Cancer Inst, 2020, 112(5): 466-479. DOI:10.1093/jnci/djz164.
[38] Melzer AC, Golden SE, Ono SS, et al.What exactly is shared decision-making? A qualitative study of shared decision-making in lung cancer screening[J]. J Gen Intern Med, 2020,35(2): 546-553. DOI:10.1007/s11606-019-05516-3.
[39] Sepucha KR, Borkhoff CM, Lally J, et al.Establishing the effectiveness of patient decision aids: key constructs and measurement instruments[J]. BMC Med Inform Decis Mak, 2013,13(Suppl 2):S12.DOI:10.1186/1472-6947-13-S2-S12.